You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Inter-alpha Inhibitors in Experimental Necrotizing Enterocolitis

    SBC: PROTHERA BIOLOGICS, INC.            Topic: NICHD

    Necrotizing enterocolitis (NEC) is a devastating acute inflammatory condition of the gastrointestinal tract resulting in intestinal necrosis, systemic sepsis and multi-system organ failure found mostly in infants born prematurely. Despite modern medical advances in the past decade, the etiology remains elusive and morbidity and mortality are still unacceptably high. It has been concluded that the ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury

    SBC: PROTHERA BIOLOGICS, INC.            Topic: 105

    Perinatal brain injury resulting in mental retardation and cerebral palsy is the most severe disability in children and affects 40-148 in preterm and 1–2/1000 in full term infants. This places a huge burden on society, emphasizing the critical need for improved prevention/treatment strategies to decrease perinatal brain injury. Hypothermia (HT) is the only FDA approved therapy to attenuate brain ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  3. MOTAR STRATFI

    SBC: DYNEPIC, INC.            Topic: J201CSO1

    Dynepic’s STRATFI solution continues the efforts of the completed Phase II SBIR to continue, extend, scale and enhance the features and capabilities of MOTAR. STRATFI funding provides the remaining core capabilities to make MOTAR a viable and sustainable XR ecosystem. MOTAR provides a secure digital infrastructure to save time and money to deliver a platform with the critical capabilities requir ...

    SBIR Phase II 2023 Department of DefenseAir Force
  4. VRSingTogether: Digital therapeutic virtual reality tool to mitigate the effects of Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD)

    SBC: RALPHVR INC            Topic: NIA

    Project Summary One in three seniors die with Alzheimer’s Disease (AD) or Alzheimer’s Disease related dementias (ADRD). More than six million Americans are living with AD and by 2050 this number is projected to rise to nearly 13 million. The economic costs of AD are significant, with 355 billion in national costs for caring for people with AD and ADRD. Disconcertingly, there is also an estimat ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  5. Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy

    SBC: STRYKAGEN CORPORATION            Topic: 100

    Abstract Duchenne Muscular Dystrophy (DMD) is a fatal muscle disease with an incidence of 1 in 5000 males. DMD results from mutations in the gene encoding dystrophin, a 427 kDa scaffolding protein responsible for providing a mechanical link between the muscle fiber actin cytoskeleton and laminin in the extracellular matrix. The α7β1 integrin is a transmembrane linkage system in skeletal and card ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  6. A breakthrough mobile phone technology that aids in early detection of COPD

    SBC: TELE-STETHOSCOPE INC.            Topic: NHLBI

    Project Summary / Abstract COPD is the fourth leading global killer, in part, because of the failure of frontline medicine to detect the disease. Poor early detection leads to unfavorable outcomes and high healthcare costs. Tele-stethoscope* or “TS” is novel technology that allows acoustic data captured from ordinary mobile phones to perform robust analysis of hemodynamics and pneumodynamics. ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  7. Time-resolved laser speckle contrast imaging of resting-state functional connectivity in neonatal brain

    SBC: BIOPTICS TECHNOLOGY LLC            Topic: 103

    ABSTRACT Continuous monitoring of neonatal brain development is crucial for effective management of brain injury and associated complications, thus reducing healthcare burden and costs. One rapidly developing method for early characterization of abnormal brain development is to map resting-state functional connectivity (rs-FC) across distinct regions of the brain. However, currently available neur ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Hidden In Plain Sight (HIPS) Wind Turbine Technology to Augment ACE Expeditionary Air Base Energy Self Sufficiency

    SBC: CBC, LLC            Topic: X224OCSO1

    CBC’s HIPS solution is a low-profile, omni-directional wind turbine that can be rapidly deployed and safely emplaced anywhere on an Agile Combat Employment (ACE) airfield without risking aircraft collisions, disrupting radar, nor requiring re-deployment t

    SBIR Phase II 2023 Department of DefenseAir Force
  9. Adaptation of Dynepic's DX Platform for Digital Asset Certification, Tracking, And Remix Capability in the USAF

    SBC: DYNEPIC, INC.            Topic: X224OCSO1

    Vendors (large and small) are being contracted to develop novel training applications leveraging the latest technologies. Because of the current siloed nature of acquisitions and program management many departments across the USAF are paying for models an

    SBIR Phase II 2023 Department of DefenseAir Force
  10. Integration of Compliance Chambers into Diaphragm Displacement Pump to Double the Pumping Flow of Pediatric Paracorporeal Pulsatile Ventricular Assist Device

    SBC: W-Z BIOTECH LLC            Topic: NHLBI

    The paracorporeal Berlin Heart EXCOR is the only FDA-approved ventricular assist device (VAD) for pediatric patients. This pulsatile diaphragm displacement pump (DDP) is small/light weight to facilitate pediatric patient ambulation. However, EXCOR efficiency is only 50% since it withdraws and pumps blood at different times (interrupted pulsatile flow). This generates a high peak blood flow rate, w ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government